Knight Therapeutics Inc. (TSX:GUD)
Canada · Delayed Price · Currency is CAD 5.90
+0.03 (0.51%)
Feb 11, 2026, 4:00 PM EST
Knight Therapeutics Market Cap
Knight Therapeutics has a market cap or net worth of CAD 582.26 million as of February 11, 2026. Its market cap has increased by 1.85% in one year.
Market Cap
582.26M
Enterprise Value
570.36M
Revenue
413.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.90
Market Cap Chart
Since March 3, 2014, Knight Therapeutics's market cap has increased from 84.40M to 582.26M, an increase of 589.90%. That is a compound annual growth rate of 17.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 582.26M | -3.07% |
| Dec 31, 2025 | 600.70M | 12.16% |
| Dec 31, 2024 | 535.57M | -0.95% |
| Dec 29, 2023 | 540.73M | -7.35% |
| Dec 30, 2022 | 583.64M | -7.29% |
| Dec 31, 2021 | 629.56M | -9.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trulieve Cannabis | 1.59B |
| Cronos Group | 1.37B |
| DRI Healthcare Trust | 902.11M |
| Verano Holdings | 642.94M |
| Canopy Growth | 566.79M |
| Cresco Labs | 517.99M |
| Cipher Pharmaceuticals | 368.85M |
| Organigram Global | 292.96M |